Retinal vein occlusion: drug targets and therapeutic implications

A Arrigo, F Bandello - Expert Opinion on Therapeutic Targets, 2021 - Taylor & Francis
Introduction The pathogenesis of retinal vein occlusion (RVO) is extremely complex and
includes several mediators. These mediators represent potential drug targets that can be …

A review of intraocular biomolecules in retinal vein occlusion: toward potential biomarkers for companion diagnostics

B Wang, X Zhang, H Chen, A Koh, C Zhao… - Frontiers in …, 2022 - frontiersin.org
Retinal vein occlusion (RVO) is one of the most common retinal vascular diseases. The
pathogenesis of RVO is multifactorial and involves a complex interplay among a variety of …

The development of risk factors and cytokines in retinal vein occlusion

Y Tang, Y Cheng, S Wang, Y Wang, P Liu… - Frontiers in Medicine, 2022 - frontiersin.org
Retinal vein occlusion (RVO) is the second most prevalent retinal disease. Despite this, the
pathogenic mechanisms and risk factors are not entirely clear. In this article, we review …

Investigational drugs for retinal vein occlusion

D Bremond-Gignac - Expert opinion on investigational drugs, 2016 - Taylor & Francis
Introduction: Retinal vein occlusion (RVO) is the second most common retinal vascular
disorder. This multifactorial disease frequently leads to visual impairment. Some risk factors …

Novel pharmaceuticals for the management of retinal vein occlusion and linked disorders

M Driban, N Kedia, S Arora… - Expert Review of Clinical …, 2023 - Taylor & Francis
Introduction Retinal vein occlusion (RVO) is the second leading cause of blindness from
retinal vascular disease behind diabetic retinopathy. Anti-vascular endothelial growth factor …

Anti-VEGF therapy for retinal vein occlusions

C Campa, G Alivernini, E Bolletta… - Current drug …, 2016 - ingentaconnect.com
Retinal vein occlusion (RVO) is the second most common cause of visual loss in the
Western World. RVO is usually classified into branch RVO (BRVO) and central RVO (CRVO) …

Best practices for treatment of retinal vein occlusion

P Hahn, S Fekrat - Current opinion in ophthalmology, 2012 - journals.lww.com
Intravitreal pharmacotherapy has revolutionized our treatment of retinal vascular diseases,
including RVO. Although these intravitreal agents are effective, our understanding of their …

Retinal vein occlusions, from basics to the latest treatment

M Ho, DTL Liu, DSC Lam, JB Jonas - Retina, 2016 - journals.lww.com
Purpose: To review the pathophysiology, diagnosis, and updated treatments of retinal vein
occlusions (RVOs). Methods: A review of the literature was performed, focusing on the …

[HTML][HTML] Pathogenesis, prevention, diagnosis and management of retinal vein occlusion

S Keren, A Loewenstein, G Coscas - World Journal of Ophthalmology, 2014 - wjgnet.com
Retinal vein occlusion (RVO) is the second vascular retinal cause of visual loss and defined
by the occlusion of a retinal vein. It is divided into branch retinal vein occlusion or central …

Mapping research trends of retinal vein occlusion from 2009 to 2018: a bibliometric analysis

F Zhao, F Du, D Shi, W Zhou, Y Jiang, L Ma - PeerJ, 2019 - peerj.com
Objectives To map publication trends and explore research hotspots of retinal vein occlusion
(RVO) study. Methods Based on Web of Science Core Collection (WoSCC), a bibliometric …